Clinical trial
An International, Multicentre, Observational, Prospective, Longitudinal Cohort Study to Assess the Impact of Integrated Upper Limb Spasticity Management Including the Use of BoNT-A- Injections on Patient-centred Goal Attainment in Real Life Practice - ULIS III
NCT02454803 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An International, Multicentre, Observational, Prospective, Longitudinal Cohort Study to Assess the Impact of Integrated Upper Limb Spasticity Management Including the Use of BoNT-A- Injections on Patient-centred Goal Attainment in Real Life Practice - ULIS III
- Lead sponsor
- Ipsen
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- June 3, 2019
- Enrollment
- 1,004 (actual)
- Sites
- 57
Conditions
As the registry lists them; a condition with its own page is linked.
upper limb spasticity